Literature DB >> 3287892

Metabolic differences between subjects whose blood pressure did or did not respond to oral calcium supplementation.

R M Lyle1, C L Melby, G C Hyner.   

Abstract

In a randomized, double-blind, placebo-controlled trial of a 1500 mg/d calcium supplement taken over a 12-wk period, the mean arterial pressure of normotensive adult males (n = 37) was modestly but significantly lowered as compared with a placebo group (n = 38). Within the Ca group only, responders (greater than or equal to 5 mm Hg decrease in mean arterial pressure, n = 14) were compared with nonresponders (less than 5 mm Hg decrease in mean arterial pressure, n = 23). The responders were older (p = 0.002) and exhibited higher mean arterial pressure (p = 0.00001), higher serum parathyroid hormone (p = 0.01), and lower serum total Ca (p = 0.001) at baseline. A stepwise discriminant function analysis revealed that mean arterial pressure and serum total Ca correctly classified 78.38% of the responders and nonresponders and, thus, were the most important determinants of blood pressure response to supplemental Ca.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287892     DOI: 10.1093/ajcn/47.6.1030

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  3 in total

Review 1.  Calcium supplementation for prevention of primary hypertension.

Authors:  Gabriela Cormick; Agustín Ciapponi; María Luisa Cafferata; María Sol Cormick; José M Belizán
Journal:  Cochrane Database Syst Rev       Date:  2022-01-11

Review 2.  Calcium supplementation for prevention of primary hypertension.

Authors:  Gabriela Cormick; Agustín Ciapponi; María Luisa Cafferata; José M Belizán
Journal:  Cochrane Database Syst Rev       Date:  2015-06-30

Review 3.  Calcium supplementation for prevention of primary hypertension.

Authors:  Gabriela Cormick; Agustín Ciapponi; María Luisa Cafferata; María Sol Cormick; José M Belizán
Journal:  Cochrane Database Syst Rev       Date:  2021-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.